{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:28:04Z","timestamp":1793525284260,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008385","name":"Fondazione per la Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100025606","name":"Chambers Family Foundation","doi-asserted-by":"publisher","award":["22\/2020"],"award-info":[{"award-number":["22\/2020"]}],"id":[{"id":"10.13039\/100025606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jcf.2024.02.013","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T01:43:57Z","timestamp":1709171037000},"page":"1153-1158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Role of viable but non culturable cells in patients with cystic fibrosis in the era of highly effective modulator therapy"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0471-875X","authenticated-orcid":false,"given":"Natalia","family":"Cirilli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Schiavoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Tagliabracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Gesuita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2358-5470","authenticated-orcid":false,"given":"Benedetta","family":"Fabrizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"D'Antuono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Peruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Cedraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Carle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Vignaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Biavasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-5879","authenticated-orcid":false,"given":"Gianmarco","family":"Mangiaterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2024.02.013_bib0001","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2024.02.013_bib0002","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00006454-199701000-00030","article-title":"Pathogenesis of bacterial bronchitis in cystic fibrosis","volume":"16","author":"Smith","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcf.2024.02.013_bib0003","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jcf.2021.06.008","article-title":"Beneath the surface: assessing cystic fibrosis pulmonary infections in the era of highly effective modulator therapy","volume":"20","author":"Waters","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2024.02.013_bib0004","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jcf.2019.07.008","article-title":"The impact of CFTR modulator therapies on CF airway microbiology","volume":"19","author":"Rogers","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.02.013_bib0005","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0154-2022","article-title":"Role of inhaled antibiotics in the era of highly effective CFTR modulators","volume":"32","author":"Elborn","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jcf.2024.02.013_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2014.10.009","article-title":"Clinical applications of pulmonary delivery of antibiotics","volume":"85","author":"Flume","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jcf.2024.02.013_bib0007","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2012.10.004","article-title":"Consensus study group. Treatment of lung infection in patients with cystic fibrosis: current and future strategies","volume":"11","author":"D\u00f6ring","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.02.013_bib0008","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.06.00100805","article-title":"Evaluating the \"Leeds criteria\" for Pseudomonas aeruginosa infection in a cystic fibrosis centre","volume":"27","author":"Proesmans","year":"2006","journal-title":"Eur Respir J"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2024.02.013_bib0009","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S1569-1993(11)60012-X","article-title":"Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF working group on outcome parameters in clinical trials","volume":"10","author":"Bilton","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.02.013_bib0010","first-page":"787","article-title":"The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis","volume":"10","author":"Sibley","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.jcf.2024.02.013_bib0011","doi-asserted-by":"crossref","first-page":"e00249","DOI":"10.1128\/JB.00249-18","article-title":"Relationship between the viable but nonculturable state and antibiotic persister cells","volume":"200","author":"Ayrapetyan","year":"2018","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.jcf.2024.02.013_bib0012","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fmicb.2014.00258","article-title":"The importance of the viable but non-culturable state in human bacterial pathogens","volume":"5","author":"Li","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jcf.2024.02.013_bib0013","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3389\/fmicb.2019.01992","article-title":"Oxygen restriction generates difficult-to-culture P. aeruginosa","volume":"10","author":"Kvich","year":"2019","journal-title":"Front. Microbiol"},{"key":"10.1016\/j.jcf.2024.02.013_bib0014","series-title":"Raccomandazioni per le indagini microbiologiche dei campioni delle vie aeree di pazienti affetti da Fibrosi Cistica","year":"2022"},{"key":"10.1016\/j.jcf.2024.02.013_bib0015","series-title":"Clinical microbiology procedures handbook","article-title":"Respiratory cultures from cystic fibrosis patients","author":"Gilligan","year":"2007"},{"key":"10.1016\/j.jcf.2024.02.013_bib0016","series-title":"UK cystic fibrosis trust microbiology laboratory standards working group laboratory standards for processing microbiological samples from people with cystic fibrosis","year":"2010"},{"key":"10.1016\/j.jcf.2024.02.013_bib0017","doi-asserted-by":"crossref","unstructured":"Mangiaterra G., Amiri M., Di Cesare A., et al. Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study. BMC Infect Dis 18(1):701 10.1186\/s12879-018-3612-9.","DOI":"10.1186\/s12879-018-3612-9"},{"key":"10.1016\/j.jcf.2024.02.013_bib0018","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.diagmicrobio.2006.02.013","article-title":"Simultaneous species identification and detection of methicillin resistance in staphylococci using triplex real-time PCR assay","volume":"56","author":"Sabet","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jcf.2024.02.013_bib0019","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/pathogens3030759","article-title":"Role of daptomycin in the induction and persistence of the viable but non-culturable state of Staphylococcus aureus biofilms","volume":"3","author":"Pasquaroli","year":"2014","journal-title":"Pathogens"},{"key":"10.1016\/j.jcf.2024.02.013_bib0020","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00284-018-1559-0","article-title":"Polymerase chain reaction assay for detection of Stenotrophomonas maltophilia in cheese samples based on the smeT gene","volume":"75","author":"Okuno","year":"2018","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.jcf.2024.02.013_bib0021","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/bjh.12703","article-title":"Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe","volume":"164","author":"Adam","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcf.2024.02.013_bib0022","doi-asserted-by":"crossref","first-page":"e79010","DOI":"10.1371\/journal.pone.0079010","article-title":"Is the improvement of CF patients, hospitalized for pulmonary exacerbation, correlated to a decrease in bacterial load?","volume":"8","author":"Deschaght","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2024.02.013_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00419-22","article-title":"Bacterial culture underestimates lung pathogen detection and infection status in cystic fibrosis","volume":"10","author":"Gavillet","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jcf.2024.02.013_bib0024","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2180-13-143","article-title":"Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis","volume":"13","author":"Le Gall","year":"2013","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jcf.2024.02.013_bib0025","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcf.2017.12.007","article-title":"One time quantitative PCR detection of Pseudomonas aeruginosa to discriminate intermittent from chronic infection in cystic fibrosis","volume":"17","author":"Boutin","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.02.013_bib0026","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AEM.66.5.1953-1959.2000","article-title":"Cell wall chemical composition of Enterococcus faecalis in the viable but nonculturable state","volume":"66","author":"Signoretto","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jcf.2024.02.013_bib0027","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1111\/1462-2920.15734","article-title":"Viable but non-cultivable state: a strategy for Staphylococcus aureus survivable in dual-species biofilms with Pseudomonas aeruginosa?","volume":"23","author":"Magalh\u00e3es","year":"2021","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.jcf.2024.02.013_bib0028","doi-asserted-by":"crossref","first-page":"e02380","DOI":"10.1128\/AEM.02380-20","article-title":"Stress resistance and pathogenicity of nonthermal-plasma-induced viable-but-nonculturable Staphylococcus aureus through energy suppression, oxidative stress defense, and immune-escape mechanisms","volume":"87","author":"Liao","year":"2021","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jcf.2024.02.013_bib0029","article-title":"Pathogenic and virulence factor detection on viable but non-culturable methicillin-resistant Staphylococcus aureus","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcf.2024.02.013_bib0030","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.3390\/ijms23073513","article-title":"The effect of CFTR modulators on airway infection in cystic fibrosis","volume":"23","author":"Harvey","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:32:51Z","timestamp":1793521971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1569199324000262"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.02.013","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of viable but non culturable cells in patients with cystic fibrosis in the era of highly effective modulator therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}